Abstract
Allogeneic stem cell transplantation (SCT) is often the final treatment modality for patients with leukemia or other hematological malignancies (Schaap et al., 1997; Thomas \& Blume …
Cite
CITATION STYLE
APA
N., D., der Meer, A. van, & Jooste, I. (2012). Licensed to Kill: Towards Natural Killer Cell Immunotherapy. In New Advances in Stem Cell Transplantation. InTech. https://doi.org/10.5772/27482
Register to see more suggestions
Mendeley helps you to discover research relevant for your work.
Already have an account? Sign in
Sign up for free